Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDGFRbeta).

Abstract:

:The t(5;12) translocation identified in patients with chronic myelomonocytic leukemia (CMML) encodes a TEL/platelet-derived growth factor receptor beta (PDGFRbeta) fusion protein. A key hypothesis for how the TEL/PDGFRbeta fusion protein would function as an oncogene is that it represents a constitutively active version of the normal PDGFRbeta. A link between the function of the t(5;12)-encoded TEL/PDGFRbeta fusion protein and Myc expression is suggested by the fact that Myc is induced by PDGF and is essential for entry of cells into the S phase of the cell cycle. We here show that the kinase activity of TEL/PDGFRbeta is necessary for Ba/F3 cells to acquire interleukin-3 (IL-3) independence and that, in contrast to their untransfected counterpart, Ba/F3 cells stably transfected with TEL/PDGFRbeta maintain a high level of Myc expression after removal of IL-3. Using dominant negative mutants of Myc, we show that a threshold of active Myc is essential for TEL/PDGFRbeta to transform Ba/F3 and Rat-1 cells. The findings that the kinase activity of TEL/PDGFRbeta and a threshold of active Myc are involved in TEL/PDGFRbeta transformation may allow for the development of therapeutic strategies in patients with t(5;12)+ CMML using specific inhibitors of the PDGFRbeta kinase as well as compounds designed to interfere specifically with Myc.

journal_name

Blood

journal_title

Blood

authors

Bourgeade MF,Défachelles AS,Cayre YE

subject

Has Abstract

pub_date

1998-05-01 00:00:00

pages

3333-9

issue

9

eissn

0006-4971

issn

1528-0020

journal_volume

91

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo.

    abstract::Angiogenesis, the development of new blood vessels from existing vasculature, is crucial for the development and metastasis of solid tumors. Here, we show for the first time that a 24-amino acid peptide derived from the amino terminus of the alpha chain of human fibrinogen (termed "alphastatin") has potent antiangioge...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2192

    authors: Staton CA,Brown NJ,Rodgers GR,Corke KP,Tazzyman S,Underwood JC,Lewis CE

    更新日期:2004-01-15 00:00:00

  • Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro.

    abstract::Latency enables human cytomegalovirus (HCMV) to persist in the hematopoietic cells of infected individuals indefinitely and prevents clearance of the pathogen. Despite its critical importance to the viral infectious cycle, viral mechanisms that contribute to latency have not been identified. We compared the ability of...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2007-01-070078

    authors: Goodrum F,Reeves M,Sinclair J,High K,Shenk T

    更新日期:2007-08-01 00:00:00

  • Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.

    abstract::Prothrombin activation can proceed through the intermediates meizothrombin or prethrombin-2. To assess the contributions that these 2 intermediates make to prothrombin activation in tissue factor (Tf)-activated blood, immunoassays were developed that measure the meizothrombin antithrombin (mTAT) and α-thrombin antithr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-427856

    authors: Whelihan MF,Zachary V,Orfeo T,Mann KG

    更新日期:2012-11-01 00:00:00

  • Clonal competition with alternating dominance in multiple myeloma.

    abstract::Emerging evidence indicates that tumors can follow several evolutionary paths over a patient's disease course. With the use of serial genomic analysis of samples collected at different points during the disease course of 28 patients with multiple myeloma, we found that the genomes of standard-risk patients show few ch...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-405985

    authors: Keats JJ,Chesi M,Egan JB,Garbitt VM,Palmer SE,Braggio E,Van Wier S,Blackburn PR,Baker AS,Dispenzieri A,Kumar S,Rajkumar SV,Carpten JD,Barrett M,Fonseca R,Stewart AK,Bergsagel PL

    更新日期:2012-08-02 00:00:00

  • Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.

    abstract::MEIS1 is a three-amino acid loop extension class homeodomain-containing homeobox (HOX) cofactor that plays key roles in normal hematopoiesis and leukemogenesis. Expression of Meis1 is rate-limiting in MLL-associated leukemias and potently interacts with Hox and NUP98-HOX genes in leukemic transformation to promote sel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-06-225573

    authors: Argiropoulos B,Yung E,Xiang P,Lo CY,Kuchenbauer F,Palmqvist L,Reindl C,Heuser M,Sekulovic S,Rosten P,Muranyi A,Goh SL,Featherstone M,Humphries RK

    更新日期:2010-05-20 00:00:00

  • CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation.

    abstract::Although double umbilical cord blood transplantation (dUCBT) in adult patients may be associated with less graft failure compared with single UCBT, hematopoietic recovery generally originates from a single cord blood unit (CBU). CBU predominance is still incompletely understood. We recently showed that blood CD4+ T-ce...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2016-06-718619

    authors: Lamers CH,Wijers R,van Bergen CA,Somers JA,Braakman E,Gratama JW,Debets R,Falkenburg JH,Cornelissen JJ

    更新日期:2016-10-27 00:00:00

  • Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.

    abstract::The risk of development of CNS leukemia was investigated in 153 adults with acute lymphocytic leukemia (ALL) who received systemic combination chemotherapy without CNS prophylaxis. Overall, 31 patients (20%) developed CNS leukemia after a median of 6 months of therapy; the estimated 1-year incidence of CNS leukemia wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kantarjian HM,Walters RS,Smith TL,Keating MJ,Barlogie B,McCredie KB,Freireich EJ

    更新日期:1988-11-01 00:00:00

  • Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation")

    abstract::Recently, we described a new genetic disorder (the "hereditary hyperferritinemia-cataract syndrome") clinically characterized by the combination of elevated serum ferritin and congenital bilateral nuclear cataract, both cotransmitted as an autosomal dominant trait. In affected subjects, hyperferritinemia (ranging from...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girelli D,Corrocher R,Bisceglia L,Olivieri O,De Franceschi L,Zelante L,Gasparini P

    更新日期:1995-12-01 00:00:00

  • Attachment of the PSGL-1 cytoplasmic domain to the actin cytoskeleton is essential for leukocyte rolling on P-selectin.

    abstract::P-selectin glycoprotein ligand-1 (PSGL-1) serves as the leukocyte ligand for P-selectin, and many of the structural features of its ectodomain required for interactions with P-selectin have been uncovered. In contrast, the function of the highly conserved PSGL-1 cytoplasmic domain has not been explored. Stable transfe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.12.4494

    authors: Snapp KR,Heitzig CE,Kansas GS

    更新日期:2002-06-15 00:00:00

  • Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

    abstract::Natural killer (NK) cells have held great promise for the immunotherapy of cancer for more than 3 decades. However, to date only modest clinical success has been achieved manipulating the NK cell compartment in patients with malignant disease. Progress in the field of NK cell receptors has revolutionized our concept o...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2002-02-0350

    authors: Farag SS,Fehniger TA,Ruggeri L,Velardi A,Caligiuri MA

    更新日期:2002-09-15 00:00:00

  • The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis.

    abstract::Glucose is a major source of energy for living organisms, and its transport in vertebrates is a universally conserved property. Of all cell lineages, human erythrocytes express the highest level of the Glut1 glucose transporter with more than 200,000 molecules per cell. However, we recently reported that erythrocyte G...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-159269

    authors: Montel-Hagen A,Blanc L,Boyer-Clavel M,Jacquet C,Vidal M,Sitbon M,Taylor N

    更新日期:2008-12-01 00:00:00

  • A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement.

    abstract::The clinical hallmark of paroxysmal nocturnal hemoglobinuria (PNH) is chronic intravascular hemolysis that is a consequence of unregulated activation of the alternative pathway of complement (APC). Intravascular hemolysis can be inhibited in patients by treatment with eculizumab, a monoclonal antibody that binds compl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-09-244285

    authors: Lindorfer MA,Pawluczkowycz AW,Peek EM,Hickman K,Taylor RP,Parker CJ

    更新日期:2010-03-18 00:00:00

  • Carfilzomib.

    abstract::This spotlight review focuses on the second-generation proteasome inhibitor carfilzomib, which was recently approved by the U.S. Food and Drug Administration for treatment of relapsed and refractory multiple myeloma patients who have received at least 2 prior therapies, including bortezomib and an immunomodulatory age...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-10-459883

    authors: Kortuem KM,Stewart AK

    更新日期:2013-02-07 00:00:00

  • Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells.

    abstract::The plasma membrane calcium pump (PMCA) is the only active Ca2+ transporter in human red blood cells (RBCs). Previous measurements of maximal Ca2+ extrusion rates (Vmax) reported only mean values in the RBC population. Despite early evidence for differences in Ca2+ extrusion capacity among RBCs, the precise Vmax distr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-06-1787

    authors: Lew VL,Daw N,Perdomo D,Etzion Z,Bookchin RM,Tiffert T

    更新日期:2003-12-01 00:00:00

  • Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.

    abstract::The effect of donor/recipient histocompatibility on relapse in patients receiving T-cell-depleted (TCD) grafts for chronic myelogenous leukemia (CML) was evaluated. Specifically, we sought to determine whether TCD results in an attenuation of the graft-versus-leukemia (GVL) effect on recipients of unrelated marrow gra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hessner MJ,Endean DJ,Casper JT,Horowitz MM,Keever-Taylor CA,Roth M,Flomenberg N,Drobyski WR

    更新日期:1995-11-15 00:00:00

  • Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.

    abstract::Serum cytokines and chemokines may reflect tumor biology and host response in follicular lymphoma (FL). To determine whether the addition of these biological factors may further refine prognostication, 30 cytokines and chemokines were measured in pretreatment serum specimens from newly diagnosed FL patients (n = 209) ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2014-06-583369

    authors: Mir MA,Maurer MJ,Ziesmer SC,Slager SL,Habermann T,Macon WR,Link BK,Syrbu S,Witzig T,Friedberg JW,Press O,LeBlanc M,Cerhan JR,Novak A,Ansell SM

    更新日期:2015-02-05 00:00:00

  • Distinct apoptotic responses imparted by c-myc and max.

    abstract::The c-myc oncoprotein accelerates programmed cell death (apoptosis) after growth factor deprivation or pharmacological insult in many cell lines. We have shown that max, the obligate c-myc heterodimeric partner protein, also promotes apoptosis after serum withdrawal in NIH3T3 fibroblasts or cytokine deprivation in int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nesbit CE,Fan S,Zhang H,Prochownik EV

    更新日期:1998-08-01 00:00:00

  • Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant.

    abstract::The original activated partial thromboplastin time-based assay for activated protein C (APC)-resistant factor Va (FVa) requires carefully prepared fresh plasma and cannot be used in patients receiving warfarin or in patients with antiphospholipid antibodies. A new test is described here that circumvents these limitati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Le DT,Griffin JH,Greengard JS,Mujumdar V,Rapaport SI

    更新日期:1995-04-01 00:00:00

  • Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

    abstract::We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consecutive related-donor (n = 177) and unrelated-donor (n = 106) allogeneic transplant recipients. Twenty-two of 165 related-donor recipients with stable or advanced disease at the time of transplant had hematologic relapse ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Enright H,Davies SM,DeFor T,Shu X,Weisdorf D,Miller W,Ramsay NK,Arthur D,Verfaillie C,Miller J,Kersey J,McGlave P

    更新日期:1996-07-15 00:00:00

  • Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.

    abstract::Aberrant activation of the Wnt pathway plays a pathogenetic role in various tumors and has been associated with adverse outcome in acute lymphoblastic leukemia (ALL). LEF1, a key mediator of Wnt signaling, has been linked to leukemic transformation, and recurrent mutations of LEF1 have been identified in pediatric T-A...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2011-04-350850

    authors: Kühnl A,Gökbuget N,Kaiser M,Schlee C,Stroux A,Burmeister T,Mochmann LH,Hoelzer D,Hofmann WK,Thiel E,Baldus CD

    更新日期:2011-12-08 00:00:00

  • Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group.

    abstract::Although infants with acute lymphoblastic leukemia (ALL) and a germline MLL gene have a better prognosis than comparable infants with a rearranged MLL gene, their optimal therapy is controversial. In 2 consecutive studies, conducted between 1996 and 2002, we treated 22 cases of infant ALL with germline MLL using chemo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2005-11-4728

    authors: Nagayama J,Tomizawa D,Koh K,Nagatoshi Y,Hotta N,Kishimoto T,Takahashi Y,Kuno T,Sugita K,Sato T,Kato K,Ogawa A,Nakahata T,Mizutani S,Horibe K,Ishii E,Japan Infant Leukemia Study Group.

    更新日期:2006-06-15 00:00:00

  • Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.

    abstract::In eighty-three patients with confirmed deep vein thrombosis, the fibrinolytic system was studied before and after a 10-minute venous occlusion. Blood was collected at least 3 months after the last acute episode, and PAI-1 antigen and activity, as well as tissue-type plasminogen activator (t-PA) antigen, urokinase-typ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nguyen G,Horellou MH,Kruithof EK,Conard J,Samama MM

    更新日期:1988-08-01 00:00:00

  • Gene therapy, an ongoing revolution.

    abstract::In this issue of Blood, Buchlis and colleagues describe the long-term persistence (up to 10 years) of factor IX (FIX) expression in adeno-associated virus serotype 2 (AAV-2)–injected muscles of a patient with hemophilia B. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-02-409086

    authors: Benveniste O

    更新日期:2012-03-29 00:00:00

  • Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.

    abstract::To directly determine whether the mechanism of activation of human plasminogen (HPg) by staphylokinase (Sak) required formation of an active complex of Sak and HPg, recombinant (r) variants of HPg were examined that allowed dissection of the steps involved in this activation. The rate of activation of wild-type (wt) r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Grella DK,Castellino FJ

    更新日期:1997-03-01 00:00:00

  • Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation.

    abstract::Expression of the myeloperoxidase (MPO) gene is tightly regulated in a tissue- and development-specific manner. Accumulation of MPO messenger RNA (mRNA) occurs only at the late myeloblastic and promyelocytic stages of myeloid differentiation and is negligible at other stages of myeloid development and in other tissues...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lübbert M,Miller CW,Koeffler HP

    更新日期:1991-07-15 00:00:00

  • Impaired granulocyte superoxide production and prolongation of the respiratory burst due to a low-affinity NADPH-dependent oxidase.

    abstract::A 7-yr-old girl with self-limited pulmonary aspergillosis was found to have a defect in granulocyte superoxide production. Her cells produced superoxide at 3% of control rates in response to phorbol myristate acetate (PMA) and opsonized zymosan. Lag times for O-2 production were normal with PMA, opsonized zymosan, and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shurin SB,Cohen HJ,Whitin JC,Newburger PE

    更新日期:1983-09-01 00:00:00

  • Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

    abstract::We have recently shown that proteasome inhibitor PS-341 induces apoptosis in drug-resistant multiple myeloma (MM) cells, inhibits binding of MM cells in the bone marrow microenvironment, and inhibits cytokines mediating MM cell growth, survival, drug resistance, and migration in vitro. PS-341 also inhibits human MM ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2543

    authors: Hideshima T,Mitsiades C,Akiyama M,Hayashi T,Chauhan D,Richardson P,Schlossman R,Podar K,Munshi NC,Mitsiades N,Anderson KC

    更新日期:2003-02-15 00:00:00

  • Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage.

    abstract::The cytokine interleukin (IL)-7 exerts essential roles in lymph node (LN) organogenesis and lymphocyte development and homeostasis. Recent studies have identified lymphatic endothelial cells (LECs) as a major source of IL-7 in LNs. Here, we report that LECs not only produce IL-7, but also express the IL-7 receptor cha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-478073

    authors: Iolyeva M,Aebischer D,Proulx ST,Willrodt AH,Ecoiffier T,Häner S,Bouchaud G,Krieg C,Onder L,Ludewig B,Santambrogio L,Boyman O,Chen L,Finke D,Halin C

    更新日期:2013-09-26 00:00:00

  • Interleukin-3 treatment of rhesus monkeys leads to increased production of histamine-releasing cells that express interleukin-3 receptors at high levels.

    abstract::To understand the hematopoietic and nonhematopoietic responses to interleukin-3 (IL-3), expression of cell-surface IL-3 receptors (IL-3R) was examined on bone marrow (BM) cells and peripheral blood (PB) cells of rhesus monkeys during the course of in vivo IL-3 treatment. Whereas IL-3R expression is low in untreated mo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Gils FC,van Teeffelen ME,Neelis KJ,Hendrikx J,Burger H,van Leen RW,Knol E,Wagemaker G,Wognum AW

    更新日期:1995-07-15 00:00:00

  • PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway.

    abstract::Cytotoxic lymphocytes clear infected and transformed cells by releasing the content of lytic granules at cytolytic synapses, and the ability of cytolytic effectors to kill in an iterative manner has been documented previously. Although bidirectional trafficking of cytolytic machinery components along the endosomal pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324160

    authors: Capuano C,Paolini R,Molfetta R,Frati L,Santoni A,Galandrini R

    更新日期:2012-03-08 00:00:00